The microbes responsible for creating the disease-causing microorganisms responsible for Lyme disease are thought to be present in the environment around us, but we know very little about how they produce the toxin that causes it.
Scientists in a new study have discovered the bacteria that cause Lyme disease.
They found that the microbes can produce the toxins needed to infect human cells.
In the study, published in the journal Science, researchers identified a particular type of toxin called pyrroloquinone triphosphate (PQT) in ticks, and found it is produced by two distinct types of bacteria.
PQT was discovered in ticks that were infected with the Lyme disease-carrying bacterium Borrelia burgdorferi, and was named after a character in a British detective novel.
The researchers discovered the toxins were produced by bacteria that live in the intestines of ticks, called Trichoderma sp.
The bacteria then use this toxin to create a toxin that can infect human blood cells, causing the disease.
PX2 is a type of bacterium that produces the toxin.
It was first isolated from a tick, and it was identified in the late 1990s, but only recently has it been detected in humans.
A key question is why ticks produce PX 2 , given the fact that they live in arid regions of the world, such as Africa.
In their new study, the scientists identified two distinct kinds of bacteria that can produce PQS.
One type of PQP, known as PX1, is produced in arctic regions.
The other type, PX3, is more common in warmer regions, such it is found in the Americas.
PZ1 is a PZ2 toxin produced in warm and humid environments.
The scientists believe that PZ 1 may be the toxin producing bacteria responsible for the disease in humans, and PZ 3 is a less active form that produces a porphyrin toxin, a more potent toxin.
They also found that PX 1 can be produced in the body by the blood cells of infected animals, as well as in the blood of healthy animals.
The study focused on ticks infected with Borrelium burgdorffi, the organism that causes Lyme disease, because that organism is common in aridity and is found naturally in ticks.
The new research is the first to demonstrate that the PZ toxin produced by the PQ2 bacteria is able to infect and infect humans, the researchers said in the press release.
“We were surprised to find that PQ1 can infect humans and is able, in some instances, to infect cells in the human immune system,” said senior author Dr. Daniela De Vos of the University of Rochester.
“But, we believe PQ3 and PXs can also be able to cause infection.”
The scientists found that there is a link between the presence of PZ toxins and the severity of the infection.
When ticks infected in the lab with PQs and PQp, the PX toxins were more toxic than the P2s.
However, when the Pz1s were given to the animals, the animals developed the disease, the authors wrote.
“Ticks infected with PZs have been shown to be highly resistant to the P1 and P2 toxins, so it is possible that PP toxins may also be capable of infecting cells in human tissues, which is consistent with our findings,” De Vose said in a press release from the University.
Researchers believe that the porphirotic toxin produced with PX 3 is more potent than the pyrrolyl hydroxytoluene (PHT) produced with the P3 toxin.
Porphirolyl tetrakisone (PNT), which is produced with both PXP and PNT, is a common toxin that is produced during infection by the bacteria Borrelae burgdorfii.
The PNT that the scientists found was much more potent and dangerous than PNT produced by PQ P2.
PNTs are known to cause severe inflammation, and researchers say PNT toxins can cause arthritis and other conditions.
“Porphirosyl tetrapylamine (PMT), the active ingredient in PNT-containing pharmaceutical products, has been implicated in the development of several neurological and metabolic disorders, including Alzheimer’s disease, Parkinson’s disease and depression,” the researchers wrote.
In addition to the study’s results, the study found that Lyme disease symptoms appeared to develop as early as three weeks after infection, and that the patients experienced more symptoms within the first week.
Researchers said that PNT is not a safe or effective treatment for Lyme, and they plan to continue their research on the toxins and how they affect humans.